FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387638802> ?p ?o ?g. }

• W4387638802 endingPage "135" @default.
• W4387638802 startingPage "127" @default.
• W4387638802 abstract "Photodynamic therapy (PDT) is actively developing, becoming one of the important methods of non-invasive treatment of various oncological and infectious diseases. It is usually carried out using three main components: a photosensitizer, light, and oxygen. The key factors for the effective use of PDT are reactogenic oxygen species, which are produced during the oxidation of photosensitizers under the influence of light irradiation.&#x0D; To increase the production of reactogenic oxygen species, a technique was proposed for creating photosensitizers with aggregation-induced emission. At the present stage in oncology, the following PDT methods using photosensitizers with aggregation-induced emission are distinguished: PDT, absorbing near infrared radiation; enzyme- or glutathione-activated PDT; hypoxic PDT, and synergistic therapy.&#x0D; Compared to visible light, near infrared radiation (7001700 nm) has been shown to be more effective and safer due to reduced photodamage, less scattering, and deeper light penetration. The development of activated photosensitizers is an effective way to overcome the uncontrolled phototoxicity of photosensitizers during long-term PDT in vivo, providing controlled death of tumor cells. The oxygen concentration in tumor tissue varies depending on tumor progression, angiogenesis, metabolism, and metastasis. Therefore, the development of photosensitizers capable of effectively fluorescing under hypoxic conditions, including catalyzing intracellular substrates with the formation of oxygen and stimulating the production of reactogenic oxygen species through the type I mechanism, has become a potential solution to the problem of PDT of solid tumors.&#x0D; The therapeutic efficacy of a single PDT method, as well as most treatment methods in modern oncology, is limited. Therefore, a significant direction is the development of multifunctional treatment systems for synergistic therapy of tumors. Synergistic chemotherapy and PDT is an important area of treatment in oncology. The combination of PDT and immunotherapy is also a promising direction in the treatment of malignant neoplasms.&#x0D; There are obvious prospects for PDT in oncology not as a separate method of treatment, but as part of a complex multimodal treatment, including chemotherapy, radiation therapy, surgical treatment, and immunotherapy." @default.
• W4387638802 created "2023-10-15" @default.
• W4387638802 creator A5011860759 @default.
• W4387638802 creator A5052930005 @default.
• W4387638802 creator A5086678049 @default.
• W4387638802 date "2023-10-14" @default.
• W4387638802 modified "2023-10-15" @default.
• W4387638802 title "Modern outlook for the use of photosensitizers with aggregation-induced emission in treatment of malignant tumors" @default.
• W4387638802 cites W1679423202 @default.
• W4387638802 cites W1994724903 @default.
• W4387638802 cites W2024066561 @default.
• W4387638802 cites W2032185182 @default.
• W4387638802 cites W2038059781 @default.
• W4387638802 cites W2043489805 @default.
• W4387638802 cites W2072298860 @default.
• W4387638802 cites W2097899798 @default.
• W4387638802 cites W2114012485 @default.
• W4387638802 cites W2135025266 @default.
• W4387638802 cites W2159182565 @default.
• W4387638802 cites W2177603935 @default.
• W4387638802 cites W2516841812 @default.
• W4387638802 cites W2536322725 @default.
• W4387638802 cites W2564584078 @default.
• W4387638802 cites W2617683824 @default.
• W4387638802 cites W2768880040 @default.
• W4387638802 cites W2808855660 @default.
• W4387638802 cites W2884902032 @default.
• W4387638802 cites W2887464310 @default.
• W4387638802 cites W2900908710 @default.
• W4387638802 cites W2943540825 @default.
• W4387638802 cites W2974017392 @default.
• W4387638802 cites W2982753862 @default.
• W4387638802 cites W2994810924 @default.
• W4387638802 cites W2997391673 @default.
• W4387638802 cites W2998570436 @default.
• W4387638802 cites W2999304663 @default.
• W4387638802 cites W3004799994 @default.
• W4387638802 cites W3005671296 @default.
• W4387638802 cites W3025476550 @default.
• W4387638802 cites W3099196694 @default.
• W4387638802 cites W3112028986 @default.
• W4387638802 cites W3120787688 @default.
• W4387638802 cites W3128196403 @default.
• W4387638802 cites W3129686976 @default.
• W4387638802 cites W3137876568 @default.
• W4387638802 cites W3149496595 @default.
• W4387638802 cites W3152019175 @default.
• W4387638802 cites W3153618119 @default.
• W4387638802 cites W3155083724 @default.
• W4387638802 cites W3164388816 @default.
• W4387638802 cites W3200223875 @default.
• W4387638802 cites W3207534757 @default.
• W4387638802 cites W4223905332 @default.
• W4387638802 cites W4226450352 @default.
• W4387638802 cites W4242591046 @default.
• W4387638802 doi "https://doi.org/10.17816/onco115221" @default.
• W4387638802 hasPublicationYear "2023" @default.
• W4387638802 type Work @default.
• W4387638802 citedByCount "0" @default.
• W4387638802 crossrefType "journal-article" @default.
• W4387638802 hasAuthorship W4387638802A5011860759 @default.
• W4387638802 hasAuthorship W4387638802A5052930005 @default.
• W4387638802 hasAuthorship W4387638802A5086678049 @default.
• W4387638802 hasBestOaLocation W43876388021 @default.
• W4387638802 hasConcept C121608353 @default.
• W4387638802 hasConcept C126322002 @default.
• W4387638802 hasConcept C178790620 @default.
• W4387638802 hasConcept C185592680 @default.
• W4387638802 hasConcept C202751555 @default.
• W4387638802 hasConcept C20639190 @default.
• W4387638802 hasConcept C2779013556 @default.
• W4387638802 hasConcept C2781323092 @default.
• W4387638802 hasConcept C2781469039 @default.
• W4387638802 hasConcept C48349386 @default.
• W4387638802 hasConcept C502942594 @default.
• W4387638802 hasConcept C509974204 @default.
• W4387638802 hasConcept C55493867 @default.
• W4387638802 hasConcept C71924100 @default.
• W4387638802 hasConcept C75473681 @default.
• W4387638802 hasConceptScore W4387638802C121608353 @default.
• W4387638802 hasConceptScore W4387638802C126322002 @default.
• W4387638802 hasConceptScore W4387638802C178790620 @default.
• W4387638802 hasConceptScore W4387638802C185592680 @default.
• W4387638802 hasConceptScore W4387638802C202751555 @default.
• W4387638802 hasConceptScore W4387638802C20639190 @default.
• W4387638802 hasConceptScore W4387638802C2779013556 @default.
• W4387638802 hasConceptScore W4387638802C2781323092 @default.
• W4387638802 hasConceptScore W4387638802C2781469039 @default.
• W4387638802 hasConceptScore W4387638802C48349386 @default.
• W4387638802 hasConceptScore W4387638802C502942594 @default.
• W4387638802 hasConceptScore W4387638802C509974204 @default.
• W4387638802 hasConceptScore W4387638802C55493867 @default.
• W4387638802 hasConceptScore W4387638802C71924100 @default.
• W4387638802 hasConceptScore W4387638802C75473681 @default.
• W4387638802 hasIssue "3" @default.
• W4387638802 hasLocation W43876388021 @default.
• W4387638802 hasOpenAccess W4387638802 @default.
• W4387638802 hasPrimaryLocation W43876388021 @default.

• next